NM_002447.4:c.1568A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002447.4(MST1R):​c.1568A>G​(p.Gln523Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.478 in 1,613,800 control chromosomes in the GnomAD database, including 192,949 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q523E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.51 ( 20913 hom., cov: 34)
Exomes 𝑓: 0.47 ( 172036 hom. )

Consequence

MST1R
NM_002447.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.968

Publications

73 publications found
Variant links:
Genes affected
MST1R (HGNC:7381): (macrophage stimulating 1 receptor) This gene encodes a cell surface receptor for macrophage-stimulating protein (MSP) with tyrosine kinase activity. The mature form of this protein is a heterodimer of disulfide-linked alpha and beta subunits, generated by proteolytic cleavage of a single-chain precursor. The beta subunit undergoes tyrosine phosphorylation upon stimulation by MSP. This protein is expressed on the ciliated epithelia of the mucociliary transport apparatus of the lung, and together with MSP, thought to be involved in host defense. Alternative splicing generates multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Jan 2016]
MST1R Gene-Disease associations (from GenCC):
  • nasopharyngeal carcinoma, susceptibility to, 3
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.325076E-6).
BP6
Variant 3-49898669-T-C is Benign according to our data. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49898669-T-C is described in CliVar as Benign. Clinvar id is 1237612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.664 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MST1RNM_002447.4 linkc.1568A>G p.Gln523Arg missense_variant Exon 4 of 20 ENST00000296474.8 NP_002438.2 Q04912-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MST1RENST00000296474.8 linkc.1568A>G p.Gln523Arg missense_variant Exon 4 of 20 1 NM_002447.4 ENSP00000296474.3 Q04912-1

Frequencies

GnomAD3 genomes
AF:
0.506
AC:
76985
AN:
152036
Hom.:
20883
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.670
Gnomad AMI
AF:
0.537
Gnomad AMR
AF:
0.398
Gnomad ASJ
AF:
0.394
Gnomad EAS
AF:
0.144
Gnomad SAS
AF:
0.234
Gnomad FIN
AF:
0.384
Gnomad MID
AF:
0.481
Gnomad NFE
AF:
0.502
Gnomad OTH
AF:
0.501
GnomAD2 exomes
AF:
0.408
AC:
102273
AN:
250958
AF XY:
0.404
show subpopulations
Gnomad AFR exome
AF:
0.677
Gnomad AMR exome
AF:
0.289
Gnomad ASJ exome
AF:
0.402
Gnomad EAS exome
AF:
0.146
Gnomad FIN exome
AF:
0.389
Gnomad NFE exome
AF:
0.497
Gnomad OTH exome
AF:
0.441
GnomAD4 exome
AF:
0.475
AC:
693707
AN:
1461646
Hom.:
172036
Cov.:
65
AF XY:
0.468
AC XY:
340478
AN XY:
727128
show subpopulations
African (AFR)
AF:
0.676
AC:
22625
AN:
33480
American (AMR)
AF:
0.303
AC:
13529
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.405
AC:
10586
AN:
26124
East Asian (EAS)
AF:
0.153
AC:
6076
AN:
39684
South Asian (SAS)
AF:
0.241
AC:
20773
AN:
86246
European-Finnish (FIN)
AF:
0.390
AC:
20795
AN:
53290
Middle Eastern (MID)
AF:
0.424
AC:
2444
AN:
5766
European-Non Finnish (NFE)
AF:
0.511
AC:
568692
AN:
1111954
Other (OTH)
AF:
0.467
AC:
28187
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
21457
42915
64372
85830
107287
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16224
32448
48672
64896
81120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.506
AC:
77063
AN:
152154
Hom.:
20913
Cov.:
34
AF XY:
0.491
AC XY:
36564
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.670
AC:
27842
AN:
41526
American (AMR)
AF:
0.398
AC:
6084
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.394
AC:
1366
AN:
3470
East Asian (EAS)
AF:
0.143
AC:
734
AN:
5132
South Asian (SAS)
AF:
0.234
AC:
1130
AN:
4830
European-Finnish (FIN)
AF:
0.384
AC:
4066
AN:
10596
Middle Eastern (MID)
AF:
0.473
AC:
139
AN:
294
European-Non Finnish (NFE)
AF:
0.502
AC:
34149
AN:
67992
Other (OTH)
AF:
0.504
AC:
1064
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1884
3768
5653
7537
9421
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
652
1304
1956
2608
3260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.494
Hom.:
52661
Bravo
AF:
0.521
TwinsUK
AF:
0.517
AC:
1916
ALSPAC
AF:
0.520
AC:
2003
ESP6500AA
AF:
0.667
AC:
2941
ESP6500EA
AF:
0.506
AC:
4350
ExAC
AF:
0.417
AC:
50578
Asia WGS
AF:
0.290
AC:
1010
AN:
3478
EpiCase
AF:
0.498
EpiControl
AF:
0.497

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 23, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MST1R-related disorder Benign:1
Oct 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.82
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.0050
DANN
Benign
0.45
DEOGEN2
Benign
0.066
T;.;.
Eigen
Benign
-2.0
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.017
N
LIST_S2
Benign
0.060
T;T;T
MetaRNN
Benign
0.0000023
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.13
N;.;N
PhyloP100
-0.97
PrimateAI
Benign
0.19
T
PROVEAN
Benign
0.48
N;.;N
REVEL
Benign
0.026
Sift
Benign
1.0
T;.;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0
B;.;.
Vest4
0.019
MPC
0.20
ClinPred
0.0063
T
GERP RS
-6.8
Varity_R
0.037
gMVP
0.53
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2230590; hg19: chr3-49936102; COSMIC: COSV56566654; COSMIC: COSV56566654; API